UPSIDE Foods, a Berkeley, California-based company that grows meat, poultry and seafood directly from animal cells, becomes the first in the world to receive approval from the U.S. Food and Drug Administration for its lab-grown meat. The FDA said that its meat product is safe for human consumption.
According to Reuters, this is the first time that the U.S. FDA has granted such approval for cultivated meat. The US agency revealed its decision on Wednesday this week. UPSIDE Foods made chicken meat by collecting cells from live animals and using them to cultivate meat inside stainless steel tanks.
With the FDA’s approval, the company may continue with its plans to sell its products. However, in a joint statement, Robert M. Califf, M.D., the commissioner of Food and Drugs - Food and Drug Administration and Susan T. Mayne, Ph.D., the director of Center for Food Safety and Applied Nutrition (CFSAN), said that before UPSIDE Foods can fully proceed with marketing the cell-cultured meat, an inspection from the U.S. Department of Agriculture (USDA) and USDA-Food Safety and Inspection Service (FSIS) are still needed.
At any rate, the American food and drug regulator further said that it had already analyzed data from UPSIDE Foods, and it has no further questions about its conclusion that the lab-grown meat is safe to eat. But then again, the FDA explained that its review is not technically an approval and pointed out that it is only for UPSIDE products and does not apply to other companies in the same business.
"This is a watershed moment in the history of food and we started UPSIDE amid a world full of skeptics, and today, we've made history again as the first company to receive a 'No Questions' letter from the FDA for cultivated meat,” UPSIDE Foods’ founder and chief executive officer, Dr. Uma Valeti, said in a press release.
The CEO added, “This milestone marks a major step towards a new era in meat production, and I'm thrilled that U.S. consumers will soon have the chance to eat delicious meat that's grown directly from animal cells."


Instagram Outage Disrupts Thousands of U.S. Users
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Trump Endorses Japan’s Sanae Takaichi Ahead of Crucial Election Amid Market and China Tensions
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Dollar Steadies Ahead of ECB and BoE Decisions as Markets Turn Risk-Off
Washington Post Publisher Will Lewis Steps Down After Layoffs
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 



